Inventor · disambiguated record
Alan Bruce Montgomery
Also filed as: MONTGOMERY ALAN B · MONTGOMERY ALAN BRUCE
35 granted patents·7 pending applications·873 citations·filing 1992–2025
97Inventor score
Files withGILEAD SCIENCES INC10CARDEAS PHARMA CORP6MONTGOMERY ALAN BRUCE5CARDEAS PHARMA INC4CORUS PHARMA INC4
Top patents by PatentIndex Score
42 records- 0195US7427633B2Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infectionsGILEAD SCIENCES INC·Filed 2007·Granted Sep 23, 2008·13 cites·36 claims
- 0294US6387886B1Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibioticCHIRON CORP·Filed 1999·Granted May 14, 2002·129 cites·22 claims
- 0394US5508269AAminoglycoside formulation for aerosolizationPATHOGENESIS CORP·Filed 1994·Granted Apr 16, 1996·246 cites·16 claims
- 0493US7452523B2Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacksGILEAD SCIENCES INC·Filed 2005·Granted Nov 18, 2008·12 cites·17 claims
- 0593US6083922AMethod and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosisPATHOGENESIS CORP·Filed 1997·Granted Jul 4, 2000·121 cites·20 claims
- 0691US6566354B1Method for treatment of bacterial infections with once or twice-weekly administered rifalazilKANEKA CORP·Filed 2001·Granted May 20, 2003·36 cites·12 claims
- 0790US8399496B2Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infectionsMONTGOMERY ALAN BRUCE·Filed 2008·Granted Mar 19, 2013·8 cites·24 claims
- 0890US7208141B2Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infectionsCORUS PHARMA INC·Filed 2003·Granted Apr 24, 2007·27 cites·30 claims
- 0990US6660249B2Inhalable dry powder aztreonam for treatment and prevention of pulmonary bacterial infectionsSALUS PHARMA INC·Filed 2001·Granted Dec 9, 2003·36 cites·16 claims
- 1089US7452524B2Method for improvement of tolerance for therapeutically effective agents delivered by inhalationGILEAD SCIENCES INC·Filed 2005·Granted Nov 18, 2008·6 cites·18 claims
- 1186US7998463B2Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough, asthma and tussive attacksGILEAD SCIENCES INC·Filed 2008·Granted Aug 16, 2011·3 cites·13 claims
- 1286US7214364B2Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infectionsCORUS PHARMA INC·Filed 2003·Granted May 8, 2007·17 cites·16 claims
- 1386US6316433B1Method for treatment of bacterial infections with once or twice-weekly administered rifalazilKANEKA CORP·Filed 1999·Granted Nov 13, 2001·50 cites·16 claims
- 1485US8841286B2Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infectionsMONTGOMERY ALAN BRUCE·Filed 2011·Granted Sep 23, 2014·2 cites·10 claims
- 1583US5767068APure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infectionsPATHOGENESIS CORP·Filed 1997·Granted Jun 16, 1998·84 cites·42 claims
- 1680US8636984B2Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisCARDEAS PHARMA INC·Filed 2013·Granted Jan 28, 2014·1 cites·11 claims
- 1780US8636983B2Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisCARDEAS PHARMA INC·Filed 2013·Granted Jan 28, 2014·1 cites·16 claims
- 1879US8820323B2Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisCARDEAS PHARMA INC·Filed 2013·Granted Sep 2, 2014·1 cites·10 claims
- 1978US7138419B2Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinateCORUS PHARMA INC·Filed 2004·Granted Nov 21, 2006·16 cites·19 claims
- 2075US8603439B2Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisMONTGOMERY ALAN BRUCE·Filed 2012·Granted Dec 10, 2013·2 cites·35 claims
- 2174US9345663B2Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infectionsGILEAD SCIENCES INC·Filed 2014·Granted May 24, 2016·0 cites·22 claims
- 2274US8003081B2Method for improvement of tolerance for therapeutically effective agents delivered by inhalationGILEAD SCIENCES INC·Filed 2008·Granted Aug 23, 2011·1 cites·21 claims
- 2374US7973029B2Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseasesGILEAD SCIENCES INC·Filed 2008·Granted Jul 5, 2011·5 cites·14 claims
- 2472US2015057242A1Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitisCARDEAS PHARMA CORP·Filed 2014·Application pending·0 cites
- 2567US8826904B2Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisCARDEAS PHARMA INC·Filed 2013·Granted Sep 9, 2014·0 cites·14 claims
- 2666US2017014389A1Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infectionsGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 2765US9533000B2Inhalable aztreonam for treatment and prevention of pulmonary bacterial infectionsGILEAD SCIENCES INC·Filed 2013·Granted Jan 3, 2017·0 cites·14 claims
- 2865US9526698B2Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisCARDEAS PHARMA CORP·Filed 2016·Granted Dec 27, 2016·0 cites·10 claims
- 2964US7772228B2Method for treatment of bacterial infections with once or twice-weekly administered rifalazilKANEKA CORP·Filed 2002·Granted Aug 10, 2010·1 cites·4 claims
- 3063US2008050439A1Inhalable aztreonam for treatment and prevention of pulmonary bacterial infectionsCORUS PHARMA INC·Filed 2007·Application pending·0 cites
- 3161US2017296517A1Inhalable aztreonam for treatment and prevention of pulmonary bacterial infectionsGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3259US9486462B2Formulations of aminoglycosides and fosfomycin in a combination having improved chemical propertiesCARDEAS PHARMA CORP·Filed 2014·Granted Nov 8, 2016·0 cites·33 claims
- 3358US2012093890A1Inhalable aztreonam for treatment and prevention of pulmonary bacterial infectionsMONTGOMERY ALAN BRUCE·Filed 2011·Application pending·0 cites
- 3457US9526697B2Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisCARDEAS PHARMA CORP·Filed 2016·Granted Dec 27, 2016·0 cites·14 claims
- 3557US9526696B2Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisCARDEAS PHARMA CORP·Filed 2016·Granted Dec 27, 2016·0 cites·9 claims
- 3657US9526695B2Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisCARDEAS PHARMA CORP·Filed 2016·Granted Dec 27, 2016·0 cites·6 claims
- 3754US10471083B2Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitisMONTGOMERY ALAN BRUCE·Filed 2012·Granted Nov 12, 2019·0 cites·5 claims
- 3852US10406171B2Formulations of aminoglycosides and fosfomycin in a combination having improved chemical propertiesSAVARA INC·Filed 2016·Granted Sep 10, 2019·0 cites·11 claims
- 3941US2006062739A1Inhalable lidocaine formulation for treatment of asthma and for reducing the need for corticosteroids in asthmatic patientsHOFMANN THOMAS·Filed 2005·Application pending·0 cites
- 4039US2025295583A1Inhaled hedgehog inhibitorsWBX PHARMA INC·Filed 2025·Application pending·0 cites
- 4137US5364615AProphylaxis of pneumocystis carinii with aerosilized pentamidineUNIV CALIFORNIA·Filed 1992·Granted Nov 15, 1994·33 cites·7 claims
- 4232US5366726ASuppression of Pneumocystis carinii using aerosolized pentamidine treatmentUNIV CALIFORNIA·Filed 1992·Granted Nov 22, 1994·22 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →